Fly News Breaks for February 27, 2015
SRPT
Feb 27, 2015 | 09:11 EDT
Cowen said Sarepta is meeting with the FDA in Q2 again on the potential NDA filing for etplirsen. Cowen believes the Sarepta will provide an increased quantity of data to the FDA but the quality will be poorer. The firm sees a lack of regulatory clarity and downgraded shares to Market Perform.
News For SRPT From the Last 2 Days
There are no results for your query SRPT